MicroPort CardioFlow Medtech Corporation (HKG:2160)
Hong Kong
· Delayed Price · Currency is HKD 0.8700
-0.0100 (-1.14%)
Jun 6, 2025, 3:59 PM HKT
HKG:2160 Revenue
In the year 2024, MicroPort CardioFlow Medtech had annual revenue of 361.57M CNY with 7.54% growth. MicroPort CardioFlow Medtech had revenue of 138.43M in the half year ending December 31, 2024, with 9.65% growth.
Revenue
361.57M CNY
Revenue Growth
+7.54%
P/S Ratio
5.46
Revenue / Employee
840.85K CNY
Employees
430
Market Cap
2.10B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BeOne Medicines | 32.53B |
| Hansoh Pharmaceutical Group Company | 13.05B |
| JD Health International | 61.89B |
| Innovent Biologics | 10.03B |
| WuXi Biologics | 19.87B |
| CSPC Pharmaceutical Group | 28.99B |
| Sino Biopharmaceutical | 30.72B |
| Sichuan Kelun-Biotech Biopharmaceutical | 2.06B |